Day One Biopharmaceuticals (DAWN) Price-to-Earnings (P/E) Ratio
Price: $7.74
Market Cap: $784.48M
Avg Volume: 1.18M
Market Cap: $784.48M
Avg Volume: 1.18M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Day One Biopharmaceuticals's P/E ratios across different time periods:
- TTM: -7.59
- Annual: -12.42
- Quarterly: -4.51
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 2.36
- Price-to-Sales (P/S) Ratio: 9.04
Annual Ratios
Day One Biopharmaceuticals Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-7.59
P/B Ratio (Annual)
2.36
P/S Ratio (Annual)
9.04
Day One Biopharmaceuticals Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -12.42 | 2.36 | 9.04 |
| 2023 | -6.17 | 3.36 | 0.00 |
| 2022 | -10.66 | -5.22 | 0.00 |
| 2021 | -14.82 | -8.19 | 0.00 |
| 2020 | -35.93 | -26.85 | 0.00 |
| 2019 | -98.93 | -136.36 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for DAWN.